Embecta (NASDAQ:EMBC) and Ethema Health (OTCMKTS:GRST) Head-To-Head Review

Embecta (NASDAQ:EMBC) and Ethema Health (OTCMKTS:GRST) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation.

Risk & Volatility

Embecta has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Ethema Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

Profitability

This table compares Embecta and Ethema Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Embecta	10.73%	-23.96%	14.12%
Ethema Health	-9.35%	N/A	-5.77%

Earnings & Valuation

This table compares Embecta and Ethema Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.08 billion	0.18	$95.40 million	$1.90	1.77
Ethema Health	$6.02 million	0.00	-$2.06 million	N/A	N/A

Embecta has higher revenue and earnings than Ethema Health.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Embecta and Ethema Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	1	3	0	0	1.75
Ethema Health	0	0	0	0	0.00

Embecta presently has a consensus target price of $15.00, indicating a potential upside of 346.43%. Given Embecta’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Embecta is more favorable than Ethema Health.

Institutional and Insider Ownership

93.8% of Embecta shares are held by institutional investors. 1.3% of Embecta shares are held by company insiders. Comparatively, 55.8% of Ethema Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Embecta beats Ethema Health on 8 of the 10 factors compared between the two stocks.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

About Ethema Health

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.